Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
73
XLY.TO Quote, Financials, Valuation and Earnings
Last price:
$0.1500
Seasonality move
:
16.48%
Day range:
$0.1450 - $0.1500
52-week range:
$0.0250 - $0.1900
Dividend yield:
0%
P/E ratio:
4.75x
P/S ratio:
1.45x
P/B ratio:
1.13x
Volume:
56.9K
Avg. volume:
1M
1-year change:
314.29%
Market cap:
$195.5M
Revenue:
$122.3M
EPS (TTM):
$0.03
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$35.9M | -- | 18.12% | -- | $0.2500 |
|
ACB.TO
Aurora Cannabis, Inc.
|
$86.5M | -$0.03 | 4.79% | -91.67% | $7.80 |
|
CRON.TO
Cronos Group, Inc.
|
$51.3M | -$0.07 | 33.92% | -156.68% | $3.95 |
|
OGI.TO
Organigram Global, Inc.
|
$73M | -$0.01 | 71.72% | -80% | $3.40 |
|
TSND.TO
Terrascend Corp.
|
$92M | -$0.03 | -12.43% | -74.49% | $1.74 |
|
WEED.TO
Canopy Growth Corp.
|
$71.8M | -$0.11 | -5.09% | -95.48% | $3.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$0.1450 | $0.2500 | $195.5M | 4.75x | $0.00 | 0% | 1.45x |
|
ACB.TO
Aurora Cannabis, Inc.
|
$6.27 | $7.80 | $354.7M | 116.20x | $0.00 | 0% | 0.96x |
|
CRON.TO
Cronos Group, Inc.
|
$3.76 | $3.95 | $1.4B | 28.61x | $0.00 | 0% | 7.82x |
|
OGI.TO
Organigram Global, Inc.
|
$2.41 | $3.40 | $324.1M | 129.47x | $0.00 | 0% | 1.20x |
|
TSND.TO
Terrascend Corp.
|
$1.10 | $1.74 | $336M | -- | $0.00 | 0% | 0.85x |
|
WEED.TO
Canopy Growth Corp.
|
$1.78 | $3.76 | $609.1M | -- | $0.00 | 0% | 1.16x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
27.67% | -1.082 | 33.75% | 1.03x |
|
ACB.TO
Aurora Cannabis, Inc.
|
15.87% | 1.055 | 19.86% | 1.52x |
|
CRON.TO
Cronos Group, Inc.
|
0.16% | 1.773 | 0.16% | 20.73x |
|
OGI.TO
Organigram Global, Inc.
|
2.45% | 2.654 | 2.31% | 1.21x |
|
TSND.TO
Terrascend Corp.
|
73.06% | 5.012 | 98.87% | 0.71x |
|
WEED.TO
Canopy Growth Corp.
|
26.05% | 4.059 | 38.43% | 4.06x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$8.8M | -$4.1M | 22.71% | 34.07% | -10.27% | $8.3M |
|
ACB.TO
Aurora Cannabis, Inc.
|
-$8M | -$56M | -9.13% | -10.69% | -61.96% | -$46.7M |
|
CRON.TO
Cronos Group, Inc.
|
$24.8M | -$6.9M | 3.71% | 3.71% | -13.83% | $12.4M |
|
OGI.TO
Organigram Global, Inc.
|
$416K | -$28M | -6.89% | -7.06% | -35.03% | -$554K |
|
TSND.TO
Terrascend Corp.
|
$44.7M | $15.3M | -14.74% | -38.6% | 17.11% | $620.3K |
|
WEED.TO
Canopy Growth Corp.
|
$16.9M | -$16.4M | -39.84% | -68.7% | -24.59% | -$19.4M |
Auxly Cannabis Group, Inc. vs. Competitors
-
Which has Higher Returns XLY.TO or ACB.TO?
Aurora Cannabis, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -58.83%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.
Company Gross Margin Earnings Per Share Invested Capital XLY.TOAuxly Cannabis Group, Inc.22.15% $0.01 $238.5M ACB.TOAurora Cannabis, Inc.-8.86% -$0.91 $667.4M -
What do Analysts Say About XLY.TO or ACB.TO?
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 72.41%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 24.4%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Aurora Cannabis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XLY.TOAuxly Cannabis Group, Inc.1 0 0 ACB.TOAurora Cannabis, Inc.2 2 0 -
Is XLY.TO or ACB.TO More Risky?
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.
-
Which is a Better Dividend Stock XLY.TO or ACB.TO?
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLY.TO or ACB.TO?
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.75x while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.45x versus 0.96x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLY.TOAuxly Cannabis Group, Inc.1.45x 4.75x $39.9M $20.5M ACB.TOAurora Cannabis, Inc.0.96x 116.20x $90.4M -$53.2M
-
Which has Higher Returns XLY.TO or CRON.TO?
Cronos Group, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of 77.94%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Cronos Group, Inc.'s return on equity of 3.71%.
Company Gross Margin Earnings Per Share Invested Capital XLY.TOAuxly Cannabis Group, Inc.22.15% $0.01 $238.5M CRON.TOCronos Group, Inc.49.47% $0.09 $1.6B -
What do Analysts Say About XLY.TO or CRON.TO?
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 72.41%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could grow by 5.05%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Cronos Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XLY.TOAuxly Cannabis Group, Inc.1 0 0 CRON.TOCronos Group, Inc.1 1 0 -
Is XLY.TO or CRON.TO More Risky?
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.
-
Which is a Better Dividend Stock XLY.TO or CRON.TO?
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLY.TO or CRON.TO?
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Cronos Group, Inc. quarterly revenues of $50.1M. Auxly Cannabis Group, Inc.'s net income of $20.5M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.75x while Cronos Group, Inc.'s PE ratio is 28.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.45x versus 7.82x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLY.TOAuxly Cannabis Group, Inc.1.45x 4.75x $39.9M $20.5M CRON.TOCronos Group, Inc.7.82x 28.61x $50.1M $39M
-
Which has Higher Returns XLY.TO or OGI.TO?
Organigram Global, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -47.42%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Organigram Global, Inc.'s return on equity of -7.06%.
Company Gross Margin Earnings Per Share Invested Capital XLY.TOAuxly Cannabis Group, Inc.22.15% $0.01 $238.5M OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M -
What do Analysts Say About XLY.TO or OGI.TO?
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 72.41%. On the other hand Organigram Global, Inc. has an analysts' consensus of $3.40 which suggests that it could grow by 41.08%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Organigram Global, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Organigram Global, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XLY.TOAuxly Cannabis Group, Inc.1 0 0 OGI.TOOrganigram Global, Inc.3 1 0 -
Is XLY.TO or OGI.TO More Risky?
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Organigram Global, Inc. has a beta of 2.213, suggesting its more volatile than the S&P 500 by 121.273%.
-
Which is a Better Dividend Stock XLY.TO or OGI.TO?
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Organigram Global, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Organigram Global, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLY.TO or OGI.TO?
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Organigram Global, Inc. quarterly revenues of $80.1M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Organigram Global, Inc.'s net income of -$38M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.75x while Organigram Global, Inc.'s PE ratio is 129.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.45x versus 1.20x for Organigram Global, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLY.TOAuxly Cannabis Group, Inc.1.45x 4.75x $39.9M $20.5M OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M
-
Which has Higher Returns XLY.TO or TSND.TO?
Terrascend Corp. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -15.22%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Terrascend Corp.'s return on equity of -38.6%.
Company Gross Margin Earnings Per Share Invested Capital XLY.TOAuxly Cannabis Group, Inc.22.15% $0.01 $238.5M TSND.TOTerrascend Corp.49.87% -$0.12 $487.1M -
What do Analysts Say About XLY.TO or TSND.TO?
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 72.41%. On the other hand Terrascend Corp. has an analysts' consensus of $1.74 which suggests that it could grow by 57.99%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Terrascend Corp., analysts believe Auxly Cannabis Group, Inc. is more attractive than Terrascend Corp..
Company Buy Ratings Hold Ratings Sell Ratings XLY.TOAuxly Cannabis Group, Inc.1 0 0 TSND.TOTerrascend Corp.4 0 0 -
Is XLY.TO or TSND.TO More Risky?
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Terrascend Corp. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.314%.
-
Which is a Better Dividend Stock XLY.TO or TSND.TO?
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Terrascend Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Terrascend Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLY.TO or TSND.TO?
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Terrascend Corp. quarterly revenues of $89.7M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Terrascend Corp.'s net income of -$13.6M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.75x while Terrascend Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.45x versus 0.85x for Terrascend Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLY.TOAuxly Cannabis Group, Inc.1.45x 4.75x $39.9M $20.5M TSND.TOTerrascend Corp.0.85x -- $89.7M -$13.6M
-
Which has Higher Returns XLY.TO or WEED.TO?
Canopy Growth Corp. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -2.46%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Canopy Growth Corp.'s return on equity of -68.7%.
Company Gross Margin Earnings Per Share Invested Capital XLY.TOAuxly Cannabis Group, Inc.22.15% $0.01 $238.5M WEED.TOCanopy Growth Corp.25.3% -$0.01 $995.3M -
What do Analysts Say About XLY.TO or WEED.TO?
Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 72.41%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 111.24%. Given that Canopy Growth Corp. has higher upside potential than Auxly Cannabis Group, Inc., analysts believe Canopy Growth Corp. is more attractive than Auxly Cannabis Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XLY.TOAuxly Cannabis Group, Inc.1 0 0 WEED.TOCanopy Growth Corp.1 4 1 -
Is XLY.TO or WEED.TO More Risky?
Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.
-
Which is a Better Dividend Stock XLY.TO or WEED.TO?
Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XLY.TO or WEED.TO?
Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Canopy Growth Corp. quarterly revenues of $66.7M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Canopy Growth Corp.'s net income of -$1.6M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.75x while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.45x versus 1.16x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XLY.TOAuxly Cannabis Group, Inc.1.45x 4.75x $39.9M $20.5M WEED.TOCanopy Growth Corp.1.16x -- $66.7M -$1.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
